NO972017D0 - Substituted tetracyclic azepine derivatives having affinity for 5-HT 2 receptors - Google Patents
Substituted tetracyclic azepine derivatives having affinity for 5-HT 2 receptorsInfo
- Publication number
- NO972017D0 NO972017D0 NO972017A NO972017A NO972017D0 NO 972017 D0 NO972017 D0 NO 972017D0 NO 972017 A NO972017 A NO 972017A NO 972017 A NO972017 A NO 972017A NO 972017 D0 NO972017 D0 NO 972017D0
- Authority
- NO
- Norway
- Prior art keywords
- receptors
- affinity
- substituted tetracyclic
- azepine derivatives
- tetracyclic azepine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/18—Dibenzazepines; Hydrogenated dibenzazepines
- C07D223/20—Dibenz [b, e] azepines; Hydrogenated dibenz [b, e] azepines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Obesity (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Hematology (AREA)
- Child & Adolescent Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Diabetes (AREA)
- Anesthesiology (AREA)
- Addiction (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP94203178 | 1994-11-02 | ||
| US08/457,968 US5552399A (en) | 1994-11-02 | 1995-05-31 | Substituted tetracyclic azepine derivatives |
| PCT/EP1995/004196 WO1996014320A1 (en) | 1994-11-02 | 1995-10-25 | Substituted tetracyclic azepine derivatives which have affinity for 5-ht2 receptors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO972017L NO972017L (en) | 1997-04-30 |
| NO972017D0 true NO972017D0 (en) | 1997-04-30 |
| NO308035B1 NO308035B1 (en) | 2000-07-10 |
Family
ID=8217337
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO972017A NO308035B1 (en) | 1994-11-02 | 1997-04-30 | Substituted tetracyclic azepine derivatives having affinity for 5-HT 2 receptors |
Country Status (30)
| Country | Link |
|---|---|
| US (1) | US5552399A (en) |
| EP (1) | EP0789701B1 (en) |
| JP (1) | JP3818541B2 (en) |
| KR (1) | KR100392060B1 (en) |
| CN (1) | CN1085667C (en) |
| AR (1) | AR002238A1 (en) |
| AT (1) | ATE199087T1 (en) |
| AU (1) | AU704285B2 (en) |
| BR (1) | BR9509552A (en) |
| CA (1) | CA2203661A1 (en) |
| CZ (1) | CZ286945B6 (en) |
| DE (1) | DE69520070T2 (en) |
| DK (1) | DK0789701T3 (en) |
| ES (1) | ES2155898T3 (en) |
| FI (1) | FI113050B (en) |
| GR (1) | GR3035680T3 (en) |
| HR (1) | HRP950537A2 (en) |
| HU (1) | HUT77408A (en) |
| IL (1) | IL115819A (en) |
| MY (1) | MY113325A (en) |
| NO (1) | NO308035B1 (en) |
| NZ (1) | NZ295656A (en) |
| PL (1) | PL183686B1 (en) |
| PT (1) | PT789701E (en) |
| RU (1) | RU2163240C2 (en) |
| SI (1) | SI0789701T1 (en) |
| TR (1) | TR199501356A2 (en) |
| TW (1) | TW349950B (en) |
| WO (1) | WO1996014320A1 (en) |
| ZA (1) | ZA959215B (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6156747A (en) * | 1996-04-12 | 2000-12-05 | Janssen Pharmaceutica N.V. | Isoxazolidine derivatives |
| UA52778C2 (en) | 1997-10-10 | 2003-01-15 | Янссен Фармацевтика Н.В. | Tetrahydrofurane halogen substituted tetracyclic derivatives, a process for production and compositions on basis thereof |
| HRP20020305A8 (en) | 2002-04-10 | 2009-03-31 | GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o. | 2-thia-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
| HRP20030885A2 (en) * | 2003-11-03 | 2005-08-31 | Pliva-Istra�iva�ki institut d.o.o. | USE OF 2-THIA-DIBENZO[e,h]AZULENES FOR THE MANUFACTURE OF PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT AND PREVENTION OF CENTRAL NERVOUS SYYTEM DISEASES AND DISORDERS |
| HRP20030953A2 (en) * | 2003-11-21 | 2005-10-31 | Pliva-Istra�iva�ki institut d.o.o. | PREPARATION OF 1-AZA-2-OXA-DIBENZO[e,h]AZULENES AND THEIR USE FOR THE MANUFACTURE OF PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT AND PREVENTION OF CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS |
| US20110086086A1 (en) * | 2005-07-26 | 2011-04-14 | Pfizer Inc | Transdermal system for varenicline |
| EP3651751A4 (en) * | 2017-07-13 | 2021-03-31 | Tonix Pharmaceuticals Holding Corp. | CYCLOBENZAPRINE ANALOGA AND AMITRYPTILES |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AT338799B (en) * | 1974-03-02 | 1977-09-12 | Boehringer Sohn Ingelheim | PROCESS FOR PREPARING NEW SUBSTITUTED 6-ARYL-4H-S-TRIAZOLO- (3,4C) -THIENO- (2,3E) -1,4-DIAZEPINE AND THEIR SALTS |
| NL7414038A (en) * | 1974-10-28 | 1976-05-03 | Akzo Nv | NEW TETRACYCLIC PYRROLIDINO DERIVATIVES. |
| DE2647114A1 (en) * | 1975-10-21 | 1977-05-05 | Hans Fickler | Linear motion drive from rotary motor - has drums of different dia. to produce high load without reduction gear |
| JPS5572177A (en) * | 1978-11-27 | 1980-05-30 | Shionogi & Co Ltd | 4,1-benzoxazepine or 4,1-benzothiazepine |
| IE903557A1 (en) * | 1989-10-05 | 1991-04-10 | Sankyo Co | Novel tetracyclic compounds having anti-allergic and¹anti-asthmatic activities, their preparation and use |
| US5512563A (en) * | 1993-07-29 | 1996-04-30 | American Cyanamid Company | Tricyclic benzazepine vasopressin antagonists |
-
1995
- 1995-05-31 US US08/457,968 patent/US5552399A/en not_active Expired - Fee Related
- 1995-10-20 TW TW084111063A patent/TW349950B/en active
- 1995-10-25 DE DE69520070T patent/DE69520070T2/en not_active Expired - Fee Related
- 1995-10-25 CN CN95195969A patent/CN1085667C/en not_active Expired - Fee Related
- 1995-10-25 SI SI9530482T patent/SI0789701T1/en unknown
- 1995-10-25 AT AT95937006T patent/ATE199087T1/en not_active IP Right Cessation
- 1995-10-25 CZ CZ19971323A patent/CZ286945B6/en not_active IP Right Cessation
- 1995-10-25 WO PCT/EP1995/004196 patent/WO1996014320A1/en not_active Ceased
- 1995-10-25 HU HU9702298A patent/HUT77408A/en unknown
- 1995-10-25 KR KR1019970702800A patent/KR100392060B1/en not_active Expired - Fee Related
- 1995-10-25 EP EP95937006A patent/EP0789701B1/en not_active Expired - Lifetime
- 1995-10-25 CA CA002203661A patent/CA2203661A1/en not_active Abandoned
- 1995-10-25 RU RU97108691/04A patent/RU2163240C2/en not_active IP Right Cessation
- 1995-10-25 PT PT95937006T patent/PT789701E/en unknown
- 1995-10-25 JP JP51500996A patent/JP3818541B2/en not_active Expired - Fee Related
- 1995-10-25 AU AU39249/95A patent/AU704285B2/en not_active Ceased
- 1995-10-25 DK DK95937006T patent/DK0789701T3/en active
- 1995-10-25 NZ NZ295656A patent/NZ295656A/en unknown
- 1995-10-25 BR BR9509552A patent/BR9509552A/en not_active IP Right Cessation
- 1995-10-25 ES ES95937006T patent/ES2155898T3/en not_active Expired - Lifetime
- 1995-10-25 PL PL95319939A patent/PL183686B1/en not_active IP Right Cessation
- 1995-10-31 ZA ZA959215A patent/ZA959215B/en unknown
- 1995-10-31 IL IL11581995A patent/IL115819A/en not_active IP Right Cessation
- 1995-10-31 HR HR08/457,968A patent/HRP950537A2/en not_active Application Discontinuation
- 1995-11-01 AR ARP950100010A patent/AR002238A1/en unknown
- 1995-11-02 MY MYPI95003312A patent/MY113325A/en unknown
- 1995-11-02 TR TR95/01356A patent/TR199501356A2/en unknown
-
1997
- 1997-04-30 NO NO972017A patent/NO308035B1/en unknown
- 1997-04-30 FI FI971854A patent/FI113050B/en not_active IP Right Cessation
-
2001
- 2001-03-30 GR GR20010400530T patent/GR3035680T3/en not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI973205A0 (en) | Indole derivatives as 5-HT receptor antagonists | |
| NO982589L (en) | 3-pyrazole-carboxamide derivatives with cannabinoid receptor affinity | |
| NO20010603D0 (en) | 2-substituted-1-piperidylbenzimidazole compounds as ORL 1 receptor agonists | |
| FI943247L (en) | Piperazine derivatives as 5-HT receptor antagonists | |
| DE69605430D1 (en) | CHINOLIN-2-ON DERIVATIVES AS SEROTONIN ANTAGONISTS | |
| DK0856001T3 (en) | Pyrimidine derivatives as 5-HT 2C receptor antagonists | |
| FI943941L (en) | Benzodiazepine derivatives useful as CCK receptor antagonists | |
| NO304693B1 (en) | Kinoxaline derivatives with affinity for quisqualate receptors | |
| NO974043D0 (en) | Indole derivatives as EAA antagonists | |
| DK0708105T3 (en) | 5-HT 4 receptor agonists | |
| AU2314195A (en) | Benzofuran derivatives as d4 receptor antagonists | |
| NO985970D0 (en) | Indoline derivatives useful as 5_HT-2C receptor antagonists | |
| NO972017L (en) | Substituted tetracyclic azepine derivatives having affinity for 5-HT 2 receptors | |
| FI951798A0 (en) | Bentzofuran derivatives as 5-HT1-like receptor antagonists | |
| KR970013921U (en) | Multi-purpose bracket for construction | |
| DK0836606T3 (en) | Condensed thiazole derivatives having 5-HT receptor affinity | |
| NO985972D0 (en) | Indoline derivatives useful as 5-HT-2C receptor antagonists | |
| NO20006041D0 (en) | N-Benzodioxanylmethyl-1-piperidylmethylamine compounds with affinity for 5-HT receptors | |
| NO943101D0 (en) | 2,6-methano-2H-quinolizine derivative as a 5-HT 3 receptor antagonist | |
| NO963775L (en) | Indole derivatives as CCK receptor antagonists | |
| KR960013523U (en) | Boring bar for inner diameter adjustment |